Jyong Biotech Ltd. Ordinary Shares Financial Flexibility Index

Latest as of December 2024: -0.02x

Jyong Biotech Ltd. Ordinary Shares financial flexibility index. Jyong Biotech Ltd. Ordinary Shares (MENS) has a Financial Flexibility Index of -0.02x as of December 2024. Free cash flow of $-913.00K (operating CF $-913.00K minus capex $0.00) represents 0% of total liabilities ($42.88 Million).

Financial Flexibility Index

-0.02x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-913.00K
Operating CF − Capex

Total Liabilities

$42.88 Million
USD

Capital Expenditures

$0.00
USD

Financial Flexibility Index of Jyong Biotech Ltd. Ordinary Shares (2020–2025)

Financial flexibility index of Jyong Biotech Ltd. Ordinary Shares from 2020 to 2025. Historical Financial Flexibility Index trend for Jyong Biotech Ltd. Ordinary Shares across 6 annual periods. Explore Jyong Biotech Ltd. Ordinary Shares cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Jyong Biotech Ltd. Ordinary Shares Financial Flexibility Index by Year (2020–2025)

Jyong Biotech Ltd. Ordinary Shares financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Jyong Biotech Ltd. Ordinary Shares. For the full cash flow conversion analysis, see Jyong Biotech Ltd. Ordinary Shares (MENS) cash conversion ratio.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.07x $-3.04 Million $-3.04 Million $45.68 Million ▲ +21.2%
2024 -0.08x $-3.62 Million $-3.62 Million $42.88 Million ▼ -37.5%
2023 -0.06x $-2.60 Million $-2.60 Million $42.32 Million ▲ +13.4%
2022 -0.07x $-2.73 Million $-2.97 Million $38.38 Million ▼ -25.9%
2021 -0.06x $-1.85 Million $-1.98 Million $32.76 Million ▼ -80.9%
2020 -0.03x $-999.00K $-1.09 Million $32.05 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities